Efficacy of a Dietary Supplement Powder Formula (Daily Ultimate Essentials) in an Adult Population.
Phase 4
Active, not recruiting
- Conditions
- Dietary Assessment
- Registration Number
- NCT06655597
- Lead Sponsor
- Prenetics Global
- Brief Summary
Healthy Adult subjects
- Detailed Description
The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 12 weeks. The subjects will attend two appointments in the clinic throughout the duration of the study.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- BMI between 18.5 and 30 kg/m2
- Low, moderate, and high activity (self-identified) *
- Self-identify as having fatigue, and abdominal issues (bloating, constipation etc.) *
- Participants will be able to read, understand and sign an informed consent form (includes HIPAA and States requirements) and sign a photo release form.
- Participants are willing and able to follow all study directions, attend study visits as scheduled and must be willing to accept the restrictions of the study including but not limited to:
- Willing to refrain from introducing any new diets or dietary supplements for the duration of the study
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Body Morphology 12 weeks Subjects assessed through weight and height which will be combined to determine BMI and abdominal and thigh circumference and images before and after
- Secondary Outcome Measures
Name Time Method Safety and Tolerability 12 weeks Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Energy 12 weeks Assessed by subjective questionnaire
Changes in Micronutrient blood levels 12 weeks Assessed through laboratory assays of vitamins and minerals in the blood
Trial Locations
- Locations (1)
San Francisco Research Institute
🇺🇸San Francisco, California, United States